Early-stage VC, Barcelona

Caixa Capital Risc

Venture capital firm · Barcelona · Founded February 2002

Quick read

Caixa Capital Risc is a Barcelona-based VC firm founded in 2002, operating as the venture capital arm of CriteriaCaixa. It backs early-stage companies across life sciences, enterprise tech, and industrial technology, primarily in Spain and Portugal, with over 200 investments to date. Its two evergreen funds — Criteria Bio Ventures and Criteria Venture Tech — now anchor its biotech and B2B SaaS strategies respectively.

Key facts

Founded
February 2002
Employees
62
Sectors
biotech, enterprise, healthcare, ai, hardware
Website
caixacapitalrisc.es

Investment thesis

Caixa Capital Risc backs early-stage companies (seed through Series B) in life sciences, enterprise tech, and industrial technology, primarily in Spain and Portugal. Its two evergreen vehicles — Criteria Bio Ventures and Criteria Venture Tech — focus on biotech/biopharma and B2B SaaS/deep tech respectively, with check sizes typically between €500K and €5M.

Recent activity

  • Jul 2026product
    Caixa Capital Risc rebranded as Criteria Capital Risc under CriteriaCaixa's 2030 Strategic Plan. The rename carries no structural changes to the firm or its portfolio. criteriacaixa.com
  • Jul 2026fundraise
    CriteriaCaixa announced a target of €300 million in investments by 2030, deployed through two evergreen funds: Criteria Bio Ventures (biotech/life sciences) and Criteria Venture Tech (technology). Primary focus remains Spain and Portugal, with selective deals in Europe and North America. Spain currently accounts for ~70% of portfolio value. ala.associates
  • Mar 2025leadership
    Jordi Ros appointed CEO (consejero delegado) of Caixa Capital Risc, effective 26 March 2025, approved by the Board of Directors. cbinsights.com
  • 2023investment
    Criteria Bio Ventures led the €27.3M Series A round for AbolerIS Pharma, a Belgian biopharmaceutical company working on treatments for autoimmune and inflammatory diseases. linkedin.com
  • Jul 2022investment
    Caixa Capital Risc led a €5.5M Series A round for Zinklar, a Barcelona-based market research platform, contributing a €1.7M ticket. Co-investors included EASO Ventures, Full Global Investments, and CDTI Innvierte. ala.associates
  • Sep 2023investment
    Criteria Bio Ventures (managed by Caixa Capital Risc) led a €27.3M Series A in AbolerIS Pharma, a Belgian biopharma developing a first-in-class immune-tolerance treatment for autoimmune diseases including rheumatoid arthritis. Sound Bioventures and Newton Biocapital co-led the round. aboleris-pharma.com
  • Sep 2023investment
    Caixa Capital Risc participated in a $5.2M round for Inari, a Barcelona-based insurtech firm targeting global insurance tech services. tracxn.com
  • 2023investment
    Criteria Venture Tech led a €3.5M round in Enline Energy Solutions, an energy infrastructure software company, to fund its global expansion. linkedin.com
  • 2022investment
    Caixa Capital Risc led a €5.5M Series A in Zinklar, a consumer insights automation platform, with a €1.7M ticket primarily from the Criteria Venture Tech fund. The round also included Beacon Capital, EASO Ventures, Full Global Investments, and CDTI Innvierte. zinklar.com
  • 2022fundraise
    Caixa Capital Risc publicly launched two new evergreen funds: Criteria Venture Tech, targeting B2B technology companies in Spain and Portugal with tickets of €500K–€2M (follow-on up to €5M), and Criteria Bio Ventures, focused on biotech and life sciences. linkedin.com
  • Jul 2021investment
    Caixa Capital Risc became a minority shareholder in AlgaEnergy alongside CDTI (Spanish state innovation body), backing the microalgae biotech company's capital increase to expand production, enter food and cosmetics markets, and grow internationally. global-agriculture.com
  • 2021investment
    Caixa Capital Risc led the sale of portfolio company Sanifit Therapeutics to Vifor Pharma for an upfront payment of €205M. Caixa Capital Risc had invested in every financing round since 2006, putting in over €23M total. ala.associates

Notable investments

Key people

Named individuals at the firm. We don't expose direct email or phone — use their LinkedIn for outreach.

  • Carlos Trenchs · Partner
  • Jordi Ros · CEO
  • Marcelino Armenter · CEO, CriteriaCaixa (parent)
  • Sebastián Müller · Director, Caixa Capital Risc

Sources

Other VCs in Spain

Explore VCs by sector

Globally

Frequently asked

What is Caixa Capital Risc?+

Caixa Capital Risc is a Barcelona-based VC firm founded in 2002, operating as the venture capital arm of CriteriaCaixa. It backs early-stage companies across life sciences, enterprise tech, and industrial technology, primarily in Spain and Portugal, with over 200 investments to date.

Where is Caixa Capital Risc headquartered?+

Caixa Capital Risc is headquartered in Barcelona, Spain.

When was Caixa Capital Risc founded?+

Caixa Capital Risc was founded in February 2002.

What sectors does Caixa Capital Risc invest in?+

Caixa Capital Risc focuses on biotech, enterprise, healthcare, ai, hardware. They primarily invest in these sectors.

Who is the CEO of Caixa Capital Risc?+

Jordi Ros is the CEO of Caixa Capital Risc.

How do I prepare for a meeting with Caixa Capital Risc?+

Brief generates a structured pre-meeting briefing on any person at Caixa Capital Risc — quick read, recent activity, points of view, and conversation openers tailored to what you sell. Sign in to get personalised openers for your product.

Meeting with someone at Caixa Capital Risc?

Brief generates a structured pre-meeting briefing on any person in seconds.

Try Brief →

Generated by briefthecall.com from public web sources. Last updated August 8, 2026. Each claim is linked to its source above.

Automatically generated by AI from public sources. May be inaccurate or out of date. Remove or correct this profile →